We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov Menu

Antiemetic Efficacy and Safety of Dexamethasone in Obstetric Surgical Patients

This study has been completed.
ClinicalTrials.gov Identifier:
First Posted: December 9, 2009
Last Update Posted: March 26, 2010
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Makerere University
December 7, 2009
December 9, 2009
March 26, 2010
January 2010
March 2010   (Final data collection date for primary outcome measure)
presence of post nausea and or vomiting [ Time Frame: 24 hours ]
Same as current
Complete list of historical versions of study NCT01028547 on ClinicalTrials.gov Archive Site
  • perianal itching [ Time Frame: 24 hours ]
  • hyperglycemia [ Time Frame: 24 hours ]
  • hypertension [ Time Frame: 24 hours ]
Same as current
Not Provided
Not Provided
Antiemetic Efficacy and Safety of Dexamethasone in Obstetric Surgical Patients
Antiemetic Efficacy and Safety of Dexamethasone in Patients Undergoing Caesarean Sections at Mulago Hospital
This is a randomised controlled double blinded clinical trial to determine the antiemetic efficacy and safety of either 8 mg of dexamethasone or normal saline (placebo) given 1 hour before induction of either spinal or general anaesthesia in 2 arms (of 150 each).
Not Provided
Not Provided
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Primary Purpose: Prevention
Postoperative Nausea and Vomiting
  • Drug: dexamethasone
    single Bolus dose of dexamethasone 8mg
  • Other: normal saline
    2 ml 0.9% saline
  • Active Comparator: dexamethasone 8mg
    Intervention: Drug: dexamethasone
  • Placebo Comparator: normal saline
    Intervention: Other: normal saline
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
March 2010
March 2010   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • all woman above 18 years old presenting for obstetric surgery and have consented to study.

Exclusion Criteria:

  • refusal/unable to consent,
  • younger than 18 years old,
  • hypertensive,
  • diabetic,
  • preeclamptic,
  • sepsis,
  • ASAIIIE plus.
Sexes Eligible for Study: Female
18 Years to 40 Years   (Adult)
Contact information is only displayed when the study is recruiting subjects
Not Provided
Not Provided
Dr Arthur Kwizera, Department of anaesthesia Makerere University College of health sciences
Makerere University
Not Provided
Study Director: Tindimwebwa J V B, MD Makerere university dept of anesthesia
Makerere University
March 2010

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP